The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no ...

Shares of Hims & Hers Health ( HIMS -24.30%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...

US stock futures (ES=F, NQ=F, YM=F) are approaching record highs from earlier in the week, but there are concerns about ...

After assuming the charges of portfolios on Friday, the Health and Transport Minister Dr Pankaj Singh on Friday said a probe ...

Delhi's new BJP-led administration announced a significant healthcare reform strategy, addressing staffing shortages, ...